Hazlett, Burt & Watson, Inc. Dexcom Inc Transaction History
Hazlett, Burt & Watson, Inc.
- $244 Million
- Q2 2025
A detailed history of Hazlett, Burt & Watson, Inc. transactions in Dexcom Inc stock. As of the latest transaction made, Hazlett, Burt & Watson, Inc. holds 100 shares of DXCM stock, worth $7,063. This represents 0.0% of its overall portfolio holdings.
Number of Shares
100
Previous 100
-0.0%
Holding current value
$7,063
Previous $7,000
28.57%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding DXCM
# of Institutions
1,111Shares Held
369MCall Options Held
5.36MPut Options Held
5.18M-
Vanguard Group Inc Valley Forge, PA48.3MShares$3.41 Billion0.07% of portfolio
-
Black Rock Inc. New York, NY34.5MShares$2.44 Billion0.09% of portfolio
-
State Street Corp Boston, MA16.9MShares$1.19 Billion0.06% of portfolio
-
Baillie Gifford & CO16.7MShares$1.18 Billion1.14% of portfolio
-
Geode Capital Management, LLC Boston, MA10.8MShares$760 Million0.07% of portfolio
About DEXCOM INC
- Ticker DXCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 386,257,984
- Market Cap $27.3B
- Description
- DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...